Creative Details

Quality Score: 3/10

The advertisement promotes a blog post discussing the necessity for the FDA to uphold strict regulations in drug manufacturing, emphasizing the risks of having unregulated pathways.

Creative Information

CID:e65585e1-ab4c-41c3-8f09-b33f48ca55e4
CRID:25_1p9oqcka
Domain:natmedia.com
Seat:TTD
Size:300x250
Bid:$2.78
Timestamp:11/26/2025, 9:19:28 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/26/2025, 10:33:25 PM6.33s
    adomain_analysissuccess11/26/2025, 11:21:02 PM4.12s
    adomain_capturesuccess11/26/2025, 11:20:21 PM0.12s
    ad_rendersuccess11/26/2025, 10:33:19 PM23.74s
    brand_mappingsuccess11/26/2025, 9:19:28 PM0.09s

    Analysis Results

    Ad Format: banner

    Brands: National Media

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:300x250
    Data Transferred:783.10 KB
    Render Time:7.58 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Law, Govt & Politics (IAB11)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Business (IAB3)
    Domain Inferred IAB Ad Products:
    • Advertising and Marketing (1011)
    • Business Services (1012)
    • Media (1419)
    • Public Relations and Strategic Communication (1023)
    Landing Page:
    Total Ad Size:802.31 KB
    Requests Made:
    URLSize (KB)
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js222.95
    https://s0.2mdn.net/sadbundle/17150314516323997159/7788b77d-b2cf-47e2-bd6c-42c9cc5b9d3f.png135.30
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N1408331.3327153SPACEBACK/B25429957.429173161;dc_ver=106.314;sz=300x250;u_sd=1;nel=1;dc_adk=2027040026;ord=oxese0;click=https%3A%2F%2Finsight.adsrvr.org%2Ftrack%2Fclk%3Fimp%3D167ef3bf-2954-422a-8c22-32cc53d62a1a%26ag%3Dsf3amgb%26sfe%3D1b5dc8ba%26sig%3DNFig0Y7Fg2T10jVv5AH2rMmOUA4jY3xMr5qgEFR3r2E.%26crid%3D1p9oqcka%26cf%3D9446854%26fq%3D0%26t%3D1%26td_s%3Dwww.newsweek.com%26rcats%3Dy29%2Cqn2%2C67m%2C5rf%26mste%3Dnewsweek.com%26mfld%3D3%26mssi%3D%26mfsi%3D%26sv%3Dkargo%26uhow%3D67%26agsa%3D%26wp%3D2.7777777%26rgz%3D02118%26dt%3DMobile%26osf%3DAndroid%26os%3DAndroid100%26br%3DChrome%26svpid%3D8565%26rlangs%3Den%26mlang%3D%26did%3D%26rcxt%3DMobileOptimizedWeb%26tmpc%3D9.650000000000034%26vrtd%3D%26osi%3D%26osv%3D%26daid%3D%26dnr%3D0%26vpb%3D%26crrelr%3D%26npt%3D2%26cc%3D2~KLUv_WMdqREMLQQVGQDzI4NROUG3XFtUbk1Uji0qx4XBy-WGZeckbcUgPpXobhwre5i4YaC76cKTQkW2XHVvRbbsuPWKR-NtRhJKnDztgCPngKjxSog6P16uPNc5dZqM8CjILUhzBk0HV6u_F5dWqNTOzxqsK7i7yYL7_hvm1rMek2vIOyZ_-usGMnlWMZ2tlXpJnUcx-KaW_cKhFSy4j1XNvm4eDf6N9Za5jn1me19cPh6Vpb2VJwvvI_Rr99uzRLI5qyOTdVWaCodRn9kebw2L7sm7jCcfc-xcJVt6Ha_cZ5EeRqPR58-6-yrjmUaeTze9Mo0957NLNkb1Xy-q269YahX6xfd6fta2XoN1XHvpvfSrOLxxL1-PzOelZO5xEhs2tuP9prTHqbWSO-_-DYSZdXEX5e2YRqky6XtBf6bQ35IRv6LAmcyr7AdejVD8uKX2fCiWGzwWq2JIbPLXlIKVmd1dXE8z2IoQhiAMVEQIy9KijpQDz59RqS-FXpX-nuf9rJNlWYfLv9_b_w3LcNzHcyY8l65uYjqpONRD7YUgJFYR8CBp4SLHijZSn0xkYEOe-SEgCA2uzanX85Ta_8CxQZfWmjuFc1LbNd5A_2H-vnPfxrWg9FGUpjf5aTSXxlZnU2xu0ngx8ISji3BPPvX5r1bxKnTAA_ZGxjDj5XU4IGwCBJXGKMj9vr7Dvg7fu67VoUKorCXWyoSZc078tz4D4JmLiNdVCHdHrWUlwSutXk7aWyG5To6REG6PPxU24-SkVYQWiWqC8eoHv7zlNeMKGe51_mvNYGDgr5ex-aL_BKOrXq2jdvj4B6k68t2OvU93L-TcpoVLh_wnhgjcNvrYH2OBlTeTBjiios1WZZQg4CgU-_Rg-9wxO7q1KQFqbWnd67FnXuNAVg7TThiEieqXGpJLGXitZtLE2bDlzJD6cBayGRUalFgEJxatVxyZMdzxIy0wLefGEkUCki5Pl2INkvcKMw-YZ3_UyFlOPVLW7trU-uERT6rwxH1NirU8oSj8yXmB-8WZdOwI7KRuN5PW95ZsHNz3MJReFvLsmii2Nk2IGOM-pyo3T6zoaiQH%26dur%3D1~KLUv_SMFoCgkgrUCALOEERWAogFJPqoLLMGuLjlARUc7Ej1t4XLDvWupY1gtmprbXyrdUe25ebVujnyWiog80A0RGxRmyNHEm-FuiNj6k-dQk2ZaAQID_LYsSUuwNufjjY2l%26durs%3DaC-OBU%26bdc%3D131%26uidd%3DYmJO7YXSpkEgvQUsLNGzvneCryN8nMuFfXPW3FoRKWyeHjfn%26idl%3DXY3007PeghpMjABoAL5j0F7eb3zh5r8dpkecAVTvg1bjhPDWk%26mk%3DAndroid%26mdl%3DGeneric%2520Android%2520Mobile%26testid%3Diavc1%2520%26car%3D509%26fpa%3D855%26pcm%3D3%26ict%3DCellularNetwork4G%26said%3D31d102b6-d373-4b20-add3-7f7c03c6def4%26auct%3D1%26us_privacy%3D1---%26tail%3D1%26r%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=mltVMH'26P;stc=1;chaa=1;sttr=37;prcl=s90.59
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://ep1.adtrafficquality.google/bg/hhg0tQcRYdMq8uFeTVyEs-1VORDs4cH4bJwltafGoS4.js53.59
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74
    https://choices.truste.com/ca?pid=tradedesk01&aid=tradedesk01&cid=drq35al_sf3amgb_1p9oqcka&c=tradedesk01cont1&js=pmw0&w=300&h=250&sid=0&dsarequired=&dsabehalf=&dsapaid=&dsaparams=21.19
    https://choices.trustarc.com/get?name=pmw2.js19.05
    https://www.googletagservices.com/dcm/dcmads.js16.68

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1